1 / 29

PLANT HEALTH RISK ASSESSMENT OF Living Modified Organisms IN THE UK

PLANT HEALTH RISK ASSESSMENT OF Living Modified Organisms IN THE UK. Alison J Wright & Paul W Bartlett Plant Health Consultants Defra, Central Science Laboratory, York, England - United Kingdom. International Plant Health Risk Analysis workshop 24 - 28 October 2005 Niagara Falls, Canada.

mort
Download Presentation

PLANT HEALTH RISK ASSESSMENT OF Living Modified Organisms IN THE UK

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. PLANT HEALTH RISK ASSESSMENT OF Living Modified Organisms IN THE UK Alison J Wright & Paul W Bartlett Plant Health Consultants Defra, Central Science Laboratory, York, England - United Kingdom International Plant Health Risk Analysis workshop 24 - 28 October 2005 Niagara Falls, Canada

  2. Outline • Legislative & administrative procedures: • LMO approval process for contained use & • deliberate release in the UK/EU; • To explain role of different authorities; In UK PH scientists directly responsible for PH assessment aligned with: • Risk analysis procedures: use of ISPM 11; • Risk of ‘Non-approved illegal LMOs’;

  3. APPROVAL OF LMOS:LEGISLATIVE BACKGROUND • LMOs intended for contained use • (EC Council Directive 90/218/EEC, as amended). • LMOs intended for deliberate release • (EC Council Directive 2001/18/EC & Regulation EC/1829/2003 on GM food & feed). • LMOs as plant pests (EC Council Directive 2000/29/EC).

  4. Legislation • Note these Directives have to be enacted as legislation in each Member State: • Thus UK has own legislation. Legislation recognises two different types of uses: • Contained use - specific containment measures are used to limit LMOs contact with the general population and the environment; • Deliberate release ‘no specific containment measures are used to limit LMOs contact with the general population & the environment;

  5. Contained Use - Approval of LMOs • In Britain, the Health & Safety Executive(HSE) is ‘competent authority’ responsible for approvals; • Persons wanting to handle a GMO must provide an Environmental risk assessments for proposed contained use of GM micro-organisms and GM plants; • How they do this is to assign a risk category for the proposed work: • Class 1 (no/negligible risk), • Class 2 (low risk), • Class 3 (moderate risk) and • Class 4 (high risk)

  6. Contained Use - Approval of MICRO-ORGANISM LMOs • If a Class 3 or 4 Environmental risk assessment on GM micro-organisms these passed to government technical advisers for comment on risks to humans, animals, plants etc.; Comment on plant health risks is provided by CSL plant health scientists; • Consent issued by HSE; If Class 1 or 2 (low risks) a risk assessment prepared but work starts – no prior approval. Most work on Plant pathogens are class 1 or 2.

  7. Contained Use - Approval of PLANT LMOs • For contained use of GM plants an environmental risk assessment (ERA) is required; • The ERA has to be retained for 10 years but the work does not have to be notified, even if risks are identified. Considered to be a weakness but Plant Health licensing currently requires prior notification and approval.

  8. Control of LMO plant pests under Plant Health legislation • In Great Britain, the Plant Health Authorities of the Department of Food & Rural Affairs (Defra) are responsible; • Plant Health licences are issued for work on plant pathogens ‘not normally present in Great Britain’. This includes LMOs. • This includes modified plant pests and LMO plants thay may contain pathogenic sequence; • Work can only commence once a licence is issued with details of containment requirements. • (being reviewed with legislation change)

  9. Examples of contained use of LMOs • LMO fungi – mutation of specific genes to examine the process of infection; • LMO viruses – Viral vectors (e.g. PVX, TNV) used to introduce novel proteins of pharmaceutical use or toxins; • LMO invertebrates – the development of a new version of Sterile insect technique.

  10. Deliberate ReleaseApproval of LMOs • In all UK, the Defra GM unit is responsible for approvals; • Separate applications for experimental releases and for marketing; • Risk assessments submitted by applicants; • Assessments sent on to government technical advisers (AH, PH, Fish, Vet. Medicines) for comment; • includes CSL Plant Health scientists; • Separate applications for either ‘experimental’ or for ‘marketing’.

  11. Deliberate Release Approval of LMOs Experimental Purposes For Research or Development. • Original risk assessment + Comments by government advisers submitted to an independent advisory body of leading scientists for examination and approval: = Advisory Committee for Releases to the Environment (ACRE) Provides advice to Ministers on risk to human health & environment; • Authorisation of experimental releases under specific conditions. (similar system for bio-control organisms but no EC legislation)

  12. Deliberate ReleasePlant health concerns • Genotypic make-up. Use of plant pathogens & pathogenic sequences e.g. Agrobacterium tumeifaciens,Cauliflower mosaic virus sequences. • Environmental. Gene flow of herbicide tolerant gene flow to soil fungi . • E.g. In Fusarium resistance work. • Concern addressed by small scale release. • Or Plant pathogen per se. • E.g. the GM bacterium produced may be pathogenic.

  13. Deliberate ReleaseExamples of UK GMO releases • Herbicide tolerance sugar beet/maize oilseed rape (canola) • Starch/carbohydrate change Potato • Virus/nematode/blight resistance Potato • Fungal resistance Wheat • Biocontrol against ‘damping-off’ fungus Bacterium [wild type Pseudomonas fluorescens used does not cause disease in (animals or) plants]

  14. Deliberate Release Approval of LMOs Marketing • Approval for marketing of LMOs and LMO products given at EC level; • May be import & processing only; • From 2004 single EC procedure for authorisation of all food & feed derived from GMO. • Member States comment on applications; • As with experimental releases, CSL plant health scientists comment and ACRE provides an opinion on environmental risks to European Food Safety Authority (EFSA) of EC Commission. • Business operators only need do one application for all EU.

  15. Examples of EU marketing consents for LMOs • For import & processing only (not to be grown in the EU): • Soya bean (herbicide tolerant); • Oilseed rape (herbicide tolerant); • Maize (insect resistant & herbicide tolerant). • For cultivation in the EU: • Tobacco (herbicide tolerant); • Maize (insect resistant & herbicide tolerant); • Carnations (modified flower colour).

  16. PLANT HEALTH RISK ASSESSMENT PROCEDURES (1) • ISPM 11 ‘PRA for quarantine pests , including analysis of environmental risks and living modified organisms’. • Principles of ISPM 11 used by plant health specialists whatever the regulatory approval process involved.

  17. PLANT HEALTH RISK ASSESSMENT PROCEDURES (2) Consider using ISPM 11. • Can the LMO be considered a plant pest? If yes, • Have the risks been adequately recognised? and • Are the risk management procedures adequate?

  18. ISPM 11 : PRA for Quarantine pestsStage 1: Initiation Can the LMO be considered a plant pest? Two types of LMOs of concern:- (i) Direct modification of a plant pest; (ii) Plants/other organisms e.g. biological control agents, which have been modified using a plant pest or modified to contain/express material derived from a plant pest.

  19. ISPM 11: PRA for Quarantine pests Stage 1: Initiation Agrobacterium tumefaciens or A. rhizogenes or other plant pests/parts of plant pests (e.g. cauliflower mosaic virus) are widely used to construct transgenic plants: BUT • Usually this is ‘disarmed’ i.e. plant pathogenic sequences removed, or • use of wild type Agrobacterium - an appropriate post-transformation antibiotic treatment has been done, => LMO is a priori considered not to be a plant pest BUT Environmental risks may still need to be examined.

  20. ISPM 11: PRA for Quarantine pests Stage 1: Initiation Construction of transgenic plants e.g. • Use of transgenes derived from plant pests e.g. virus coat proteins to convey disease resistance; • Use of modified virus as a vector for gene delivery into plants e.g. for synthesis of novel proteins of pharmaceutical use. => LMO plant considered a potential plant pest

  21. ISPM 11: PRA for Quarantine pests Stage 2: Pest Risk Assessment Risk criteria for LMOs in Annex 3 to ISPM 11 include consideration of :- • Changes in adaptive characteristics; • Adverse effects of gene transfer or gene flow; • Adverse effects on non-target organisms; • Genotypic instability or phenotypic instability; • Other e.g. enhanced capacity for virus recombination.

  22. ISPM 11: PRA for Quarantine pests Stage 2: Pest Risk Assessment RA generally concerned with phenotypic characteristics but Genotypic characteristics also need to be considered: e.g. use of wild type Agrobacterium tumefaciens Also if non-indigenous source used for construction, the PH risk of the genetic material has to be assessed.

  23. ISPM 11: PRA for Quarantine pests Stage 3: Pest Risk Management What is the acceptable level of risk? • Refer to level of risk accepted for similar (parent) organisms; • Depends on intended use:- • For Contained use? • For planting or not?

  24. ISPM 11: PRA for Quarantine pests Stage 3: Pest Risk Management Examples from marketing approvals: Oil seed rape (canola) for processing - controls on transport to processing plant; Maize for planting - Low risk of viable seed being produced in the UK (no volunteers).

  25. RISK ANALYSIS OF NON-APPROVED LMOs ‘Risk alert’ of a non-approved LMO by:- • PRA of commodity pathway as a result of an import request; • Monitoring by the LMO authority for imports of non-approved LMOs or by plant health inspection services in their routine import checks.

  26. RISK ANALYSIS OF NON-APPROVED LMOs LMO issues for a PRA of a commodity pathway: • Knowledge of worldwide LMO releases? E.g. in Asia? • Direct risk from LMO plants. E.g. altered host range cf. parent plant; • Hitch-hiker risk from a e.g. LMO biological control agents.

  27. RISK ANALYSIS OF NON-APPROVED LMOs LMO issues arises from LMO monitoring/plant health import checks: Need for good molecular diagnostic techniques to distinguish non-approved LMO from either non-modified parent plant or any similar approved LMO plants.

  28. Compliance • In UK have combined inspectorate for • Border; • Exports; • Marketing/Certification of planting material; • Seeds; • Containment facilities for Research etc.. • The Plant Health & Seeds Inspectorate • Field control of Deliberate release of GM by the GM Inspectorate in CSL Plant Health Group

  29. Conclusions • In the UK, scientists of the plant health service are directly involved in risk analysis for risks to plants and the environment. • ISPM 11 provides the framework for phytosanitary PRA for LMOs (micro-organisms & plants). • Under current EC legislation, consents for importation of LMO plants are handled by GM authorities in UK/EFSA at EU level. Plant health authorities are consulted. • Plant health services will need to consider how they incorporate assessment of LMO risks in import commodity PRAs.

More Related